http://www.mmm-online.com/approval/topic/214/ Articles tagged with Approval from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The FDA approved the Breo/Ellipta combo, but analysts are wary about its potential to go beyond the COPD indication in the US. http://www.mmm-online.com/gsk-adds-competitor-to-copd-market/article/292934/ Fri, 10 May 2013 20:43:31 GMT The FDA approved the Breo/Ellipta combo, but analysts are wary about its potential to go beyond the COPD indication in the US. MMM Arena gets closer to the market place, Takeda scoops up privately held Inviragen, Plan B court decision is coming and Cubist antibotic lands breakthrough therapy status. http://www.mmm-online.com/business-briefs-arena-takeda-teva-cubist/article/292521/ Wed, 08 May 2013 17:05:17 GMT Arena gets closer to the market place, Takeda scoops up privately held Inviragen, Plan B court decision is coming and Cubist antibotic lands breakthrough therapy status. MMM A new FDA site gives patients a one-stop shop for commenting on pending regulations, finding clinical trials and navigating treatment options. http://www.mmm-online.com/fda-streamlines-patient-access-information/article/292080/ Mon, 06 May 2013 15:58:20 GMT A new FDA site gives patients a one-stop shop for commenting on pending regulations, finding clinical trials and navigating treatment options. MMM FDA is accelerating review of Pfizer's experimental breast cancer drug palbociclib, which analysts say already has a fan base among KOLs. http://www.mmm-online.com/pfizer-pipeline-breast-cancer-drug-gets-fast-tracked/article/288456/ Thu, 11 Apr 2013 17:05:52 GMT FDA is accelerating review of Pfizer's experimental breast cancer drug palbociclib, which analysts say already has a fan base among KOLs. MMM The FDA has approved Janssen's Invokana (canagliflozin) for type 2 diabetes, giving J&J a first-to-market advantage in the SGLT-2 class. http://www.mmm-online.com/jjs-invokana-clears-fda/article/286749/ Fri, 29 Mar 2013 21:59:39 GMT The FDA has approved Janssen's Invokana (canagliflozin) for type 2 diabetes, giving J&J a first-to-market advantage in the SGLT-2 class. MMM Sobi and Savient Pharmaceuticals inked a co-promote agreement for RA drug Kineret in the US. http://www.mmm-online.com/business-briefs-sobi-and-savient-novartis-saatchi-saatchi-wellness/article/280972/ Tue, 19 Feb 2013 21:03:43 GMT Sobi and Savient Pharmaceuticals inked a co-promote agreement for RA drug Kineret in the US. MMM Johnson & Johnson is said to be shopping its women's division; Genzyme lands a rare disease drug approval; Roche says Avastin had a comeback in 2012; promotions at Ogilvy CommonHealth and McCann Complete Medical http://www.mmm-online.com/business-briefs-jj-genzyme-roche/article/278284/ Wed, 30 Jan 2013 20:23:14 GMT Johnson & Johnson is said to be shopping its women's division; Genzyme lands a rare disease drug approval; Roche says Avastin had a comeback in 2012; promotions at Ogilvy CommonHealth and McCann Complete Medical MMM CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers. http://www.mmm-online.com/jj-otc-sales-slipped-3-in-2012-worldwide/article/277043/ Tue, 22 Jan 2013 18:19:42 GMT CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers. MMM The FDA approved a flu vaccine that can be produced quickly, and lacks many elements that make patients skittish. http://www.mmm-online.com/egg-free-mercury-free-flu-vaccine-approved/article/276541/ Thu, 17 Jan 2013 18:11:49 GMT The FDA approved a flu vaccine that can be produced quickly, and lacks many elements that make patients skittish. MMM Generic Plavix was just the beginning of blood-thinner transformation. Eliquis is poised to benefit from lessons learned and pre-existing goodwill. http://www.mmm-online.com/eliquis-the-third-shoe-drops-in-the-blood-thinner-category/article/275647/ Thu, 10 Jan 2013 19:35:42 GMT Generic Plavix was just the beginning of blood-thinner transformation. Eliquis is poised to benefit from lessons learned and pre-existing goodwill. MMM